Kayne Anderson Rudnick Investment Management LLC increased its stake in shares of Endava plc (NYSE:DAVA - Free Report) by 22.8% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 4,533,111 shares of the company's stock after buying an additional 842,433 shares during the quarter. Kayne Anderson Rudnick Investment Management LLC owned 7.68% of Endava worth $140,073,000 at the end of the most recent reporting period.
Other large investors have also recently bought and sold shares of the company. Assetmark Inc. raised its stake in shares of Endava by 93.1% in the fourth quarter. Assetmark Inc. now owns 985 shares of the company's stock worth $30,000 after acquiring an additional 475 shares during the last quarter. Blue Trust Inc. raised its position in Endava by 28.5% in the 4th quarter. Blue Trust Inc. now owns 1,494 shares of the company's stock worth $46,000 after purchasing an additional 331 shares during the last quarter. Quadrant Capital Group LLC lifted its holdings in Endava by 114.2% during the 4th quarter. Quadrant Capital Group LLC now owns 1,474 shares of the company's stock worth $46,000 after buying an additional 786 shares in the last quarter. GAMMA Investing LLC boosted its position in Endava by 86.4% in the 4th quarter. GAMMA Investing LLC now owns 1,607 shares of the company's stock valued at $50,000 after buying an additional 745 shares during the last quarter. Finally, PNC Financial Services Group Inc. boosted its position in Endava by 60.4% in the 4th quarter. PNC Financial Services Group Inc. now owns 4,086 shares of the company's stock valued at $126,000 after buying an additional 1,538 shares during the last quarter. 62.23% of the stock is currently owned by institutional investors.
Endava Trading Down 1.9 %
Shares of DAVA traded down $0.35 during trading hours on Friday, reaching $18.54. The stock had a trading volume of 191,244 shares, compared to its average volume of 481,461. The company has a market cap of $1.09 billion, a P/E ratio of 168.45, a P/E/G ratio of 2.26 and a beta of 1.33. Endava plc has a 52 week low of $16.60 and a 52 week high of $34.94. The company has a quick ratio of 1.90, a current ratio of 1.90 and a debt-to-equity ratio of 0.21. The firm has a 50-day moving average of $21.11 and a 200 day moving average of $26.47.
Endava (NYSE:DAVA - Get Free Report) last released its quarterly earnings results on Thursday, February 20th. The company reported $0.14 EPS for the quarter, missing analysts' consensus estimates of $0.32 by ($0.18). Endava had a return on equity of 0.89% and a net margin of 0.74%. The business had revenue of $250.63 million for the quarter, compared to analyst estimates of $197.33 million. On average, sell-side analysts expect that Endava plc will post 0.57 earnings per share for the current fiscal year.
Analyst Ratings Changes
Several equities analysts have recently issued reports on the company. Susquehanna cut their price target on Endava from $55.00 to $50.00 and set a "positive" rating on the stock in a research note on Friday, February 21st. Needham & Company LLC reduced their target price on shares of Endava from $43.00 to $38.00 and set a "buy" rating on the stock in a research note on Friday, February 21st. Finally, Morgan Stanley boosted their price target on shares of Endava from $33.00 to $35.00 and gave the stock an "equal weight" rating in a research note on Friday, January 31st. Four equities research analysts have rated the stock with a hold rating and seven have given a buy rating to the company. According to data from MarketBeat, the company has a consensus rating of "Moderate Buy" and a consensus price target of $39.10.
Read Our Latest Analysis on DAVA
Endava Profile
(
Free Report)
Endava plc provides technology services for clients in the consumer products, healthcare, mobility, and retail verticals in North America, Europe, the United Kingdom, and internationally. It offers ideation and production services in the payments and financial services, telecommunications, media, and technology verticals; and business analysis, data analytics, program management, digital product strategy, private equity value enhancement, IT strategy, architecture, extended reality, machine learning and artificial intelligence, product design, and user experience and visual design services.
Further Reading
Before you consider Endava, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Endava wasn't on the list.
While Endava currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.
Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
